Cannabis Report
Home > Boards > US OTC > Biotechs >

Oncolix Inc. (ONCX)

ONCX RSS Feed
Add ONCX Price Alert      Hide Sticky   Hide Intro
Moderator: reaper247, BeeDoubleU, Rat Fink, namtae, AltJactUp, steadyhand
Search This Board: 
Last Post: 7/16/2018 1:11:22 AM - Followers: 157 - Board type: Free - Posts Today: 1



A pharmaceutical company in Harris County, Texas.
OTCQB: ONCX

14405 Walters Rd, Houston, TX 77014
(281) 402-3168
Contact Us
\

Oncolix, Inc. (Oncolix) is a clinical-stage biotechnology company

We are developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers. The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in our first indication, the treatment of ovarian cancer.  This clinical trial began in 2016. Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat. Prolanta™ is a prolactin receptor antagonist that has demonstrated significant efficacy in xenograft models through a unique mechanism of action, autophagy (see Our Science). In addition to ovarian cancer, there is strong preclinical evidence Prolanta™ will be effective in breast, prostate and other cancers.

The FDA has also approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer, which may allow reduced filing fees, federal tax credits and marketing exclusivity by the FDA.

Proudly partnered with Greenville Health System

Oncolix, Inc. (Oncolix) is a bio-pharmaceutical company originally established at the Greenville Health System through the innovative efforts of the Oncology Research Institute in conjunction with the GHS Cancer Center drug discovery program. Oncolix, now based in Houston, Texas, is currently focusing on phase one clinical trials of Prolanta™ - a targeted therapeutic protein for the treatment of breast and ovarian cancer. Prolanta™ was pioneered within the Oncology Research Institute (now known as the Clemson Biomedical Institute) at GHS in Greenville, SC.


Proudly partnered with MD Anderson Cancer Treatment Center


MD Anderson has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report’s “Best Hospitals” survey.

 

Oncolix patents

Oncolix has 30 patents in their patent portfolio, including 8 U.S patents.

\

 
ONCX Security Details
Share Structure
  Market Value1 $5,801,028 a/o Dec 01, 2017
Authorized Shares 950,000,000 a/o Dec 01, 2017
Outstanding Shares 103,877,936 a/o Dec 01, 2017
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 33,311,633 a/o Apr 06, 2017
  Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 101 a/o Apr 06, 2017

As per OTC markets. Updates are pending


Who is Oncolix, Inc.?

https://oncolixbio.com

April 2017 Company Presentation:
https://nebula.wsimg.com/8b544fcbb6f5bf5fb52c1c7e5a69eb81?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1

 

Early funding for Prolactin research was granted from the Susan G. Komen foundation and the U.S government.
More recent funding came from accredited investment including TEXAS TREASURY SAFEKEEPING TRUST CO and the Ernest Mario Family Trust.
Ernest Mario is an American pharmaceutical industry executive and the recipient of the 2007 Remington Honor Medal awarded by the American Pharmacists Association.

 

\

Ernest Mario is the former CEO of GlaxoSmithKilne NYSE: GSK.

He is also Rutgers University alumni who has had the Rutgers School of Pharmacy named after him.


Potential revenue moving forward.

 

 

The Oncolix Team

Management

\

\

Board Members

\

\

\

Prolanta Inventor

\

Company Advisors

\

\



 




 


This space reserved for updates.

 



https://www.otcm
arkets.com/edgar/GetFilingHtml?FilingID=12149068

Cannabis Report
ONCX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AEPP News: Statement of Ownership (sc 13g) 02/16/2018 10:50:47 AM
AEPP News: Amended Statement of Beneficial Ownership (3/a) 02/15/2018 11:24:44 AM
AEPP News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 02/09/2018 06:13:48 AM
AEPP News: Notice of Effectiveness (effect) 02/09/2018 06:01:55 AM
AEPP News: Securities Registration Statement (s-1/a) 02/05/2018 11:57:32 AM
PlusOneCoin Top Posts
#18026   Hahaha, laraz, reaper247 07/11/18 02:56:24 AM
#14803   None of those Patents belong to Oncolix, they laraz5 12/17/17 10:58:21 PM
PostSubject
#18064  Sticky Note ONCX JULY 2018 "BREAKTHROUGH TECHNOLOGY_FOR_WOMEN'S_CANCERS"_PRESENTATION Rat Fink 07/16/18 01:11:22 AM
#17985  Sticky Note That would be true except for the fact namtae 07/02/18 07:40:02 AM
#17849  Sticky Note Oncolix OTC: ONCX is a pharmaceutical company that reaper247 06/07/18 12:10:14 AM
#17139  Sticky Note Cutting through the ONCX clutter and nonsense. reaper247 03/22/18 01:12:28 AM
#18064   ONCX JULY 2018 "BREAKTHROUGH TECHNOLOGY_FOR_WOMEN'S_CANCERS"_PRESENTATION Rat Fink 07/16/18 01:11:22 AM
#18063   Is 3 year old pre clinical trial info laraz5 07/15/18 08:26:52 PM
#18062   HERE IS M.D. ANDERSON'S PRE-CLINICAL_TRIAL_INFO_ON_PROLANTA/G129R>>>[ Rat Fink 07/14/18 09:12:31 PM
#18061   BIOPHARMA ONCX/ONCOLIX HAS "8" U.S. PATENTS_&_MANY_FOREIGN_PATENTS! Rat Fink 07/14/18 05:17:06 PM
#18059   That's a disgrace The Greenville Health system controlled laraz5 07/14/18 09:00:35 AM
#18058   Yesterday was 900 days Prolanta was in clinical BLight1911 07/13/18 04:46:05 PM
#18057   Its been 895 days since Prolanta has been in phase laraz5 07/13/18 03:54:03 PM
#18056   Its dead here, just like the stock namtae 07/13/18 03:08:48 PM
#18054   Imagine "VP of Corp development" cannot answer questions laraz5 07/12/18 11:15:06 AM
#18052   VERY SUCCESSFUL MD ANDERSON PRE-CLINICAL_TRIAL_OF_ONCOLIX_PROLANTA/G129R[/ Rat Fink 07/12/18 10:08:49 AM
#18051   Even though his title is VP Corp Dev, namtae 07/12/18 10:05:59 AM
#18050   7/5/18 PR: "ONCX" EXPANDS MANAGEMENT TEAM_WITH_NEW_VP_OF_CORPORATE_DEVELOP Rat Fink 07/12/18 09:56:26 AM
#18048   Could be he doesnt know or could be namtae 07/12/18 09:40:12 AM
#18047   Spoke to Andrew Scott but he refused to laraz5 07/12/18 09:32:47 AM
#18046   BIOPHARMA ONCX/ONCOLIX HAS "8" U.S. PATENTS_&_MANY_FOREIGN_PATENTS! Rat Fink 07/12/18 12:31:29 AM
#18045   ONCX JULY 2018 "BREAKTHROUGH TECHNOLOGY_FOR_WOMEN'S_CANCERS"_PRESENTATION!!! Rat Fink 07/12/18 12:26:22 AM
#18044   Thanks for the clarification. AltJactUp 07/11/18 03:32:17 PM
#18043   It almost seems like they are intentionally dragging dabullishbear 07/11/18 03:32:11 PM
#18042   Prolanta was originally developed to treat breast cancer, dabullishbear 07/11/18 03:29:55 PM
#18041   900 days of Clinical trial where are the results? laraz5 07/11/18 02:00:25 PM
#18040   Agreed!! Where are those results or has anyone even namtae 07/11/18 01:09:10 PM
#18039   I’ll settle for an update on the phase AltJactUp 07/11/18 01:05:07 PM
#18038   The new slide deck must have triggered over namtae 07/11/18 01:03:26 PM
#18037   I saw it.. Pharma partner Breast Cancer To be BeeDoubleU 07/11/18 12:43:56 PM
#18036   Gynecological cancers are first, but if you check AltJactUp 07/11/18 12:40:15 PM
#18035   Without a Manufacturer of Prolanta you really are laraz5 07/11/18 11:28:59 AM
#18034   I believed they targeting gynecologic cancers.. BeeDoubleU 07/11/18 11:00:45 AM
#18033   If Prolanta is effective against uterine cancer, they AltJactUp 07/11/18 10:40:21 AM
#18032   Wow, all that theft and a major decrease laraz5 07/11/18 10:38:12 AM
#18031   Milestones ? FINRA due diligence ? ChangetickertoONCX ? BeeDoubleU 07/11/18 10:29:31 AM
#18030   Scientific and Clinical Advisory Board First member(s) to BeeDoubleU 07/11/18 10:27:42 AM
#18029   They also updated the press releases on the AltJactUp 07/11/18 10:26:26 AM
#18028   Another big investor willing to put up millions BeeDoubleU 07/11/18 10:25:01 AM
#18027   New slide deck out: https://oncolixbio.com/wp-content/uploads/oncx-slide-deck-07 AltJactUp 07/11/18 10:06:08 AM
#18026   Hahaha, laraz, reaper247 07/11/18 02:56:24 AM
#18025   HERE IS M.D. ANDERSON'S PRE-CLINICAL_TRIAL_INFO_ON_PROLANTA/G129R>>>[ Rat Fink 07/10/18 10:28:15 PM
#18024   ONCX SHAREHOLDERS "HOLDING" THEIR_ONCX_SHARES!!! Rat Fink 07/10/18 10:27:19 PM
#18023   LOL!? BLight1911 07/10/18 10:24:11 AM
#18022   This could be the biggest bust in US laraz5 07/10/18 08:42:50 AM
#18021   Its been 892 days since Prolanta has been in phase laraz5 07/10/18 08:31:32 AM
#18020   New prospectus and other filings out. AltJactUp 07/10/18 08:16:47 AM
#18019   Pfffttt namtae, reaper247 07/10/18 12:23:47 AM
#18018   Maybe theyll put out a PR about the namtae 07/09/18 02:01:55 PM
#18017   Oinks is really stinking it up again today. BillG2436 07/09/18 01:45:07 PM
#18016   I agree? The R/S will happen once the laraz5 07/09/18 10:11:54 AM
#18015   GREAT CEO INTERVIEW ON PROLANTA_DEVELOPMENT_FOR_WOMEN'S_CANCERS_(12/6/17) Rat Fink 07/09/18 10:04:57 AM
#18014   BIOPHARMA ONCX/ONCOLIX HAS "8" U.S. PATENTS_&_MANY_FOREIGN_PATENTS! Rat Fink 07/09/18 10:03:48 AM
#18013   Well, beginning with multiple statements of misinformation about namtae 07/09/18 07:52:50 AM
#18012   LOL laraz, reaper247 07/09/18 01:51:05 AM
#18011   OUTSTANDING PRESENTATION ON ONCOLIXs_PROLANTA_EFFECTS_ON_WOMENs_CANCERS!!! Rat Fink 07/07/18 11:34:57 PM
PostSubject